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ABSTRACT:

Chapter 1: Biophysical investigation of the cataract associated mutant, E107A of
human gamma-D crystallin.
Several human genetic cataracts are associated with mutations in a single amino acid
residue of the protein known as D crystallin. Recently, the Glu107Ala (or E107A) mutation has
been included in this list, and it has been associated with a nuclear congenital cataract. We
have made recombinant human D crystallin and its E107A mutant and conducted preliminary
comparisons of its structure and biophysical properties with that of the wild-type protein. In
this process we made use of several techniques – Circular Dichroism (CD), Iso-electric focusing
(IEF) gels, Dynamic Light Scattering (DLS), and Nuclear Magnetic Resonance (NMR). Results
highlight small structural changes while the overall protein structure remains folded and intact.

Chapter 2: Constructing a fluorescent system for manipulating PIP2
concentration in the plasma membrane of Xenopus Oocytes.
Potassium channels play a key role in electric activity of excitable cells. Dysfunction of
these ion channels may result in neuronal, cardiac, and muscular disorders. Several subfamilies
of potassium channels are regulated via G-protein coupled receptor signaling pathway and the
signaling molecule PIP2 may affect potassium channel activity. To understand how PIP2
regulates potassium channels, we are going to construct a unique fluorescent system to
manipulate the PIP2 levels in the plasma membrane of Xenopus oocytes, an ideal heterologous
expression system for studying function of ion channels. We plan to heterologously express
2
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membrane-attached FRB-CFP fusion protein and cytoplamic RFP-FKBP12-phosphoinositide 5phosphatase fusion protein in Xenopus oocytes. Application of rapamycin will result in
heterodimerization of a FKBP12 protein with FRB protein. This process will increase the
concentration of phosphoinositide 5-phosphatase and lower the concentration of PIP2 in the
membrane of Xenopus oocytes. Accordingly the fluorescent signals will change during this
process. With site-directed mutagenesis and sub-cloning strategies, we successfully made a
construct that expresses RFP-FKBP12 fusion protein in Xenopus oocytes. This construct will be
used as a negative control in this system.
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Chapter 1
Biophysical investigation of the cataract associated mutant, E107A of human
gamma-D crystallin

INTRODUCTION:

Proteins are macromolecules that have diverse functions in the human body. They can
be found virtually in every cell and are of many types: enzymes, antibodies, contractile proteins,
hormonal proteins, and many more types.
The most abundant proteins found in the vertebrate eye lens belong to a group called
crystallins, of which there are three major subgroups α, β, and γ, based on their decreasing
molecular weights [1-3]. Those proteins are responsible for the refractive properties of the lens.
, β, and γ crystallins are encoded by CRA-, CRB-, and CRG- genes respectively [4]. Only theCrystallins were found to act as molecular chaperones and protect a lens against stress [4].
Those functions may be altered by mutations in CRAA and CRAB genes many of which are found
to be associated with disorders such as cataract, desmin-related myopathy or dilated
cardiomypathy [4].The and γ crystallins were found to have mainly refractive properties [5].
Multiple single point mutations in one member of the -crystallin family, Human Gamma D
crystallin, are linked to a number of well known cataract phenotypes. The CRGD gene is one of
the most abundantly expressed γ –crystallin genes in the human lens [6-8].
Cataract belongs to a class of diseases commonly referred to as protein-misfolding
disorders; however the disease associated mutation may or may not lead to conformational
change [9-11]. Instead the protein undergoes a significant loss of solubility leading to the
16

formation of several insoluble phases that can be amorphous, crystalline, or gel-like [12] which
lead to increased light scattering and opacity.
The P23T mutant in particular has been associated with coralliform, cerulean, and
fasciculiform cataract phenotypes [13-15], whereas the E107A mutant has been associated with
nuclear congenital cataract [16]. Both of these mutations are characterized as single point
mutations of Human Gamma D (HGD) protein, and were found to be associated with formation
of cataract in the human eye. In our laboratory we have focused on the latter mutation, which
was observed specifically in nuclear congenital cataract. This disorder is characterized by
opacity in the center portion of the eye lens and can be detected sometime before the first year
after birth [16]. The E107A mutation involves a substitution of a negatively charged glutamic
acid residue with a neutral alanine at position 107 along the amino acid sequence. This causes
not only a change in the charge of the protein, but also a change in the size of the residue at
this position, since alanine has a smaller side chain than glutamic acid.
As first step towards understanding the mechanism of how the E107A mutation leads to
opacity, we proceeded to compare the solution structures and biophysical characteristics of the
recombinant E107A mutant with wild-type HGD. We collected NMR, DLS and CD data for HGD
and E107A and examined if there was a change in the pI of the native protein due to the
mutation, using isoelectric focusing gels.
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METHODS AND MATERIALS:

Expression and Isolation of the Protein:
In order to overexpress the protein (HGD and E107A mutant) the E. coli cultures,
containing DNA encoding the protein, were grown in LB broth at 37˚C until the absorbance at
600 nm reached 0.6 (until induction). Isopropyl 1-thiol-D-galactopyranoside (IPTG) was added
to induce expression of gamma crystallins and the cultures were grown in a M9 minimal
medium containing ampicillin, containing 1 g/L [U–15N]NH4Cl and 2 g/L D-glucose (for [U-,15N]labeled protein). The growth was terminated when the absorbance at 600nm reached 1.
Centrifugation was used to pellet the cells which then were resuspended in the NMR buffer (10
mM KPO4 (pH 7.0), 100 mM NaCl, 0.02% NaN3, 90% H2O and 10% D2O) containing complete
protease inhibitor (1tablet/30mL, from Roche Molecular Biochemicals), followed by lysis
initiated using lysozyme (250µg/mL, from chick egg white). Next, seven cycles of a freeze-thaw
procedure were carried out in which the cell suspension was frozen in liquid nitrogen followed
by thawing in water bath set to approximately 30˚C. Sonication procedure was then used for
one minute at the highest power setting. DNase (1 mg/mL, Turbo DNAse from Ambion) was
added to the resulting suspension which was then centrifuged at 48,400 x g for 15 minutes.
Magnesium (8 mM) was added to the supernatant followed by one hour incubation and
addition of DTT (10 mM). The final pH was brought to 4.5 with acetic acid. Concentration of the
purified protein was determined using an extinction coefficient of 41.4 mM -1•cm-1 at 280nm
wavelength [17].
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Nuclear Magnetic Resonance Spectroscopy:
The NMR spectroscopy data was collected by Mr. Jian Chao Zhang in collaboration with
Prof. Alexander Shekhtman.
Data was collected at 25˚C in a Bruker Avance spectrometer, operating at 500 MHz 1H
frequency. In order to perform backbone chemical shift assignment standard double and triple
resonance NMR experiments, 2D 1H–15N HSQC and 3D CBCA (CO)NH, HNCACO, HNCO, and
HNCACB, were used [18]. TOPSPIN 2.1 (Bruker, Inc.) software was used to process all of the
spectra and CARA software was used to perform the chemical shift assignments [19].

Circular Dichroism Spectroscopy:
The CD spectra were obtained by Dr. Ajay Pande.
CD spectra were obtained using a Jasco (Easton, MD) model J-810. Protein solutions
were in 0.1M sodium phosphate buffer, pH 7. Concentration of 0.41mg/mL and 1.23mg/mL was
used for E107A mutant and HGD samples respectively.

Quasielastic Light Scattering:
A Wyatt Dynapro MS/X dynamic scattering system with Peltier temperature control was
used to measure the hydrodynamic radii and the size distribution of the particles in the protein
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samples. Protein concentrations ranging from 1.25 mg/mL to 5.00 mg/mL were used in 0.1M
sodium phosphate buffer, pH 7.

Isoelectric Focusing Gel Electrophoresis:
IEF gel electrophoresis was performed using the IEF Minicell from Bio-Rad. 5%
acrylamide gel (5% acrylamide, 5% glycerol, 2% ampholyte, pH 3-10) was prepared. Gel solution
was then degassed for 5 minutes followed by the addition of 0.2% TEMED, 0.03% APS, and
0.03% riboflavin 5’-monophosphate (FMN). The gel was left to solidify for about 45 minutes
under an open fluorescent light. The gel was placed in the Minicell and current was applied
using the PowerPac Basic Power Supply from Bio-Rad, for approximately 45 minutes. Following
completion of the run, the gel was stained for one hour with shaking in IEF staining solution
(27% Ethanol, 10% Acetic Acid, 0.04% Coomassie Brilliant Blue, 0.5% CuSO4, 0.05% Crocein
Scarlet). The gel was de-stained by incubating in de-staining buffer-I for an hour with shaking
(12% Ethanol, 7% Acetic Acid, 0.5% CuSO4), followed by overnight incubation with shaking in IEF
de-stain II (25% Ethanol, 7% Acetic Acid). Protein bands were visualized on a Chemi-Doc gel
documentation system from Bio-Rad labs.
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Modeling:
The high resolution, 3D x-ray crystal structure of HGD was displayed by importing the
coordinates from the Protein Data Bank and using the Swiss-PDB Viewer (PDB structure 1hk0;
resolution 1.25Å; ref. 20).

Results:
Comparison of Isoelectric Point:
Isoelectric focusing (IEF) gels revealed an increase in the isoelectric point due to the
mutation (Figure 1.1).

Fig. 1.1. IEF gel for E107A mutant and native HGD protein. The IEF standard
(from Bio-Rad) can be seen on the left hand side (marked as STD). The middle
band corresponds to the E107A mutant (2mg/mL). Native HGD protein (2mg/mL)
was loaded on the right hand side of the gel. The mutant protein appears to have
a pI value of 9.6 where as the wild type HGD protein appears to have pI of 7.6.
The lower, less visible bands are most likely due to the post-translational
modifications of the protein.

11
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The most intense band on the IEF gel for E107A appeared at a pI of 9.6 for the mutant
protein and around 7.6 for wild-type HGD. Lower, less intense bands can also be seen. These
bands are typical for IEF gels and may be due to post-translational modifications of a protein
such as deamidation. This observed difference in pI value was expected since the mutation
leads to a change in the total charge of the protein.

Protein Structure Comparison:
In this project two spectroscopic windows were used in CD measurements, far and near
UV, in order to gain an insight into the differences in secondary and tertiary structure of E107A
and HGD (figures 1.2 and 1.3). The data obtained from the sample containing E107A mutant
protein was overlaid with the wild-type HGD data. Far UV circular dichroism measurements
reveal a strong positive peak at a wavelength of about 198 nm and a slight negative peak
around 222 nm (figure 1.2).

Figure 1.2. Far UV CD data for E107A (pink curve) and HGD (dark blue curve). The
numerical data was converted into a graph which revealed a strong positive peak around
198 nm and a weaker, negative peak around 222 nm. This is indicative of the presence of β
pleated sheets in both proteins. The two proteins seem to be composed mostly of those
motifs. The data suggest that the single point mutation had no significant effect on the
secondary structure of the protein.
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This corresponds to a pattern consistent with a protein composed mostly of a β pleated
sheet motif. The data shows that the structure of E107A remains predominantly -pleated
sheet and that the secondary structures of both proteins are nearly identical.
Data obtained in the near UV-CD region shows two strong, negative peaks, one around
290 nm and another around 300 nm (Figure 1.3). The close correspondence of the two curves
again strongly suggests that the tertiary structures of the protein were not significantly altered
by the single point mutation.

Figure 1.3. Near UV CD data for E107A mutant (pink curve) and native HGD protein (dark blue
curve). The data obtained from near UV CD was used to create the above curves. In result two,
relatively strong, negative peaks emerged in both curves, around a wavelength of 290nm and
300nm. Both pink and dark blue curve follow the same pattern and are nearly ideally
superimposed on each other indicating that there was little or no change in the tertiary structure
of the protein due to the single point mutation.

The NMR data was analyzed using Cara software. First about 90% of E107A mutant
residues were assigned, and then the data corresponding to both native and mutant protein
was overlaid on the HSQC spectrum (figure 1.4). Most of the peaks obtained from the NMR
measurements of the two proteins appear in the same region on the HSQC spectrum.
13
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Figure 1.4. NMR, HSQC spectrum for E107A (red) and HGD (black) protein. The
chemical shifts of the residues in both proteins produced a similar pattern. The data
suggests that there is no significant difference between the two proteins and most of
the peaks appear to be superimposable.

Like-Like, Protein-Protein Interactions Comparison:
Dynamic light scattering measurements were done on the mutant and wild-type
proteins with concentrations ranging from 1.25mg/mL to 5.00 mg/mL. The data shows that
there is no significant difference in like-like protein-protein interactions between the two
protein species (figure 1.5, table 1.1). Hydrodynamic radius data collected for HGD were nearly
identical to that collected for E107A. The largest difference in the size of the hydrodynamic radii
of the two proteins was 0.06 nm. There was also little variation observed in the data
corresponding to the percent polydispersity of E107A and HGD protein. The greatest difference
in the obtained values was 1.6 %.
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b)

a)
HGD, 1.25mg/mL

E107A, 1.25mg/mL

c)

d)
E107A, 2.50mg/mL

HGD, 2.50mg/mL

f)

e)

E107A, 5.00mg/mL

HGD, 5.00mg/mL

Fig. 1.5. Dynamic Light Scattering Data. Data collected using Dyna Pro DLS machine from Watt Technology were
converted into histograms. This figure shows just a representative fraction of the DLS data that was collected in
our laboratory. The light blue bars are due to impurities, such as dust, that were present in the sample. The dark
blue bars represent the part of data that corresponds to the protein of interest. Each sample had either
1.25mg/mL (parts a and b), 2.5mg/mL( parts c and d), or 5.00mg/mL(parts e and f) concentration of the protein
of interest. The data was collected for both E107A mutant (parts b,d, and f) and wild-type HGD (parts a,c, and e).
This data was also tabulated (see table 1.1).
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Table 1.1. DLS Data for 1.25mg/mL – 5.00mg/mL E107A mutant and 1.25mg/mL – 5.00mg/mL HGD protein.

Concentration
(mg/mL)
1.25
2.50
5.00

HGD
R(nm)
2.23
2.71
2.32

E107A
%Pd
11.70
12.80
12.40

R(mn)
2.27
2.77
2.32

%Pd
13.30
13.60
12.50

Percent polydispersity (%Pd) was quite low for both proteins. This indicates that all of
the samples contained protein molecules in a monomeric state (%Pd ≤ 20%). This was expected
for HGD but not for E107A.

Modeling:
The structure of E107A was modeled on the high resolution x-ray crystal structure of
HGD which shows that Human Gamma D crystallin and its E107A mutant are composed of two
domains (Figure1.6). The mutation site can be seen at the edge of the C-terminal domain. The
acidic, additional carboxylate group of glutamic acid is shown in red.

16
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A

E107
B

A107
Fig. 1.6. A ribbon diagram of the x-ray structure of HGD [19] and the homology
model of E107A. A) Human Gamma D protein with Glu107 involved in substitution
shown as a space filling model. B) A model of E107A using PDB viewer software,
showing A107 residue as a space filling model.

DISCUSSION:

We have shown that the isoelectric point of E107A mutant is higher than the isoelectric
point of negatively charged HGD protein. Preliminary data show that the observed difference
was about two pI points. One of the sources notes that the isoelectric point of gamma-D
crystallins in mammals ranges from pH7.1 to pH 8.6 [4], which is consistent with our findings for
17
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HGD of about 7.6. While we expected a higher pI value for E107A based on the nature of the
amino acid substitution, the actual magnitude of 9.6 may not be accurate because the IEF
standard used has a low resolution in the pI range of 7.8 to 9.6. This made it difficult to obtain a
better estimate of the pI value for the E107A mutant.
Using Dynamic Light Scattering, we have also shown that there are no significant
changes in like-like protein-protein interactions in E107A compared to HGD. Both proteins show
a low percentage of polydispersity and are predominantly monomeric, which indicates that
neither protein undergoes aggregation under our measurement conditions. The hydrodynamic
radii of both proteins also appeared to be the same, and are about 2.43 nm. This finding shows
that the shape of the molecule did not change due to the amino acid substitution. From this
observation we can conclude that the size distribution properties of E107A mutant and native
HGD protein are the same when the protein concentration ranges from 1.25mg/mL to
5.00mg/mL. There exists a small possibility that the results will differ if the measurements are
taken for the proteins at their physical concentration, 300-400 mg/mL.
Similarly, based on our current results, the amino acid substitution does not seem to
have an influence on the secondary or tertiary structure of the protein. This is shown in the
results from circular dichroism and NMR measurements. High dispersion of the peaks in both
15

N and 1H dimensions on HSQC spectrum (Figure 1.4) indicates that the protein structure (of

both E107A mutant and native HGD) is well folded. This is confirmed by the far UV CD spectrum
(Figure 1.2) which indicates that both protein species are composed mostly of β pleated sheet
motifs and very little if any random coil regions. If the tertiary structure of the protein was in a
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random coil state then the near UV CD spectra of the mutant would not resemble that of the
wild-type. Since our data shows a clear near UV CD spectra for both E107A mutant and native
HGD, we can conclude that both protein species are well folded. This is consistent with all of
our results. The small differences in CD spectra of both proteins may be due to the loss of a
hydrogen bond; this is a result of substitution of polar residue by non-polar residue. Difference
in far-UV CD spectra around 200 nm wavelength is most likely due to a small reorganizations in
the peptide backbone.
Our data suggest that the cataract-associated E107A mutation is very similar to wildtype HGD in its secondary and tertiary structure and like-like protein-protein interactions. Thus,
the manner in which it leads to increased light scattering and opacity is still unclear. However,
in this project we have only examined like-like protein-protein interactions. The question
remains as to what will happen if we look at interactions between E107A and a crystallin
species other than human gamma-D crystallin. Since the other major class of water soluble
proteins in the lens is alpha-crystallin, it is reasonable to assume that there might be
differences in the interaction between E107A and the alpha crystallin. Such an interaction may
reveal how the E107A mutation leads to like-unlike protein aggregation, increased light
scattering and opacity in the affected eye lens.

CONCLUSION:

In our project we have shown that there are no significant conformational changes
observed in the cataract-associated E107A mutant compared to the wild-type HGD protein. We
19
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have also shown that the secondary structure of both proteins is composed predominantly of βsheet. This mutation is the first example in which the like-like protein-protein interactions in a
cataract-associated mutant of human D crystallin are indistinguishable from those of the wildtype, such that the mutant protein is as soluble as the wild-type, and no novel light scattering
elements (e.g. crystals, fibers or gels) are formed. Thus, the question of how this mutation leads
to increased light scattering and lens opacity remains to be addressed.

ACKNOWLEDGEMENTS:

-NMR data taken by Mr. Jian Chao Zhang in collaboration with Prof. Alexander Shekhtman.
-CD data taken by Dr. Ajay Pande.
This work was supported by an RO1 grant from the National Institutes of Health to
Professor Jayanti Pande.

20
15

REFERENCES:

1.
2.
3.
4.
5.
6.

Mörner CT (1893) Z Physiol Chem 18:61-106.
Siezen JR, Fisch RM, Slingsby C, Benedek BG (1985) Proc Natl Acad Sci 82:1701-1705.
Vérétout F, Delaye M, Tardieu A (1989) J Mol Biol 205:713–728.
Graw J (2009) Experimental Eye Research 88:173-189.
Tomarev IS (1996) Eur J Biochem 235:449-465.
Aarts HJ, den Dunnen JT, Leunissen J, Lubsen NH, Schoenmakers JG (1988) J Mol Evol
27:163-172.
7. Hejtmancik JF (1998) Am. J. Hum Genet 62:520-525.
8. Santhiya ST, Shyam Manohar M, Rawlley D, Vijayalakshmi P, Namperualsamy P,
Gopinath PM, Loster J, Graw J (2002) J Med Genet 39:352-358.
9. Kmoch S, Brynda J, Befekadu A, Bezouška K, Novák P, Rezácová P, Ondrová L, Filipec M,
Sedlácek J, Elleder M (2000) Hum Mol Genet 9:1779-1786.
10. Pande A, Pande J, Asherie N, Lomakin A, Ogun O, King AJ, Lubsen HN, Walton D, Benedek BG
(2000) Proc Natl Acad Sci 97:1993-1998.
11. Pande A, Pande J, Asherie N, Lomakin A, Ogun O, Kind J, Benedek BG (2001) Proc Natl Acad
Sci 98:6116-6120.
12. Pande A, Annunziata O, Asherie N, Ogun O, Benedek BG, Pande J (2005) Biochemistry
44:2491-2500.
13. Pande A, Anunziata O, Asheric N, Ogun O, Benedek GB, Pande J (2005) Biochemistry
44:2491-2500.
14. Evans P, Wyatt K, Wistow GJ, Bateman OA, Wallace B, Slingsby C (2004) J Mol Biol
343:435-444.
15. Khan OA, Aldahmesh AM, Ghadhfan EF, Al-Mesfer S, Alkuraya SF (2009) Mol Vis
15:1407-1411.
16. Messina-Baas MO, Gonzalez-Huerta ML, Cuevas-Covarrubias AS (2006) Mol Vis 12:995-1000.
17. Andley UP, Mathur S, Griest TA, Petrash JM (1996) J Biol Chem 271:31973-31980.
18. Cavanagh J, Fairbrother JW, Palmer GA, Rance M, Skelton JN (2007) “Protein NMR
Spectroscopy: Principles and Practice, second ed.” Academic Press, Amsterdam, Boston,
pp.533–678.
19. Masse EJ, Keller R (2005) J. Magn. Reson. 174:133–151.
20. Basak AK, Bateman O, Slingsby C, Pande A, Asherie N, Ogun O, Benedek G, Pande J
(2003) J Mol Biol 328:1137-1147.

21
16

Chapter 2
Constructing a fluorescent system for manipulating PIP2 concentration in the plasma
membrane of Xenopus Oocytes.
INTRODUCTION:

Malfunction of potassium ion channels can cause disorders such as hypokalemic
periodic paralysis (hypoPP) [1], congenital deafness [2], or long-QT syndrome, a type of cardiac
arrhythmia [3]. These channelopathies can be prevented by altering the activity of ion channels,
which induces a change in blood potassium concentration. One possible way to accomplish this
could be through alteration of phosphatidylinositol 4,5-biphosphate(PIP2) concentration in the
cell membrane.
PIP2 Concentration was found to influence the function of transporters and several ion
channels such as [4] (KCNQ1/KCNE1), voltage-gated potassium channels [5], and cardiac
sodium-calcium exchangers (NCX1) [6]. It is a molecule that serves as a signaling phospholipid
of the plasma membrane and it constitutes a large portion of total phosphoinositide species in
mammalian cells [7]. Fluctuations in PIP2 concentration were shown to influence the activity of
KCNQ and other ion channels. For example, Binding of PIP2 activates KCNQ K+ channels [8].
Similarly hydrolysis of PIP2 by phospholipase C can cause depletion of PIP2 in the cell membrane
that leads to reduction in the activity of KCNQ K+ ion channels. It was speculated that those
changes in PIP2 concentration could be caused by factors such as aging, affective states or
simply stress [9].
In order to determine the extent to which PIP2 concentration influences activity of ion
channels one must be able to visualize this signaling molecule in a cell and alter its
22
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concentration without disturbing cell’s integrity. This task was accomplished in few laboratories
by creating a system with two protein constructs. One construct consists of a fluorescent
protein fused to the pleckstrin homology (PH) domain of human PLC 1 that specifically binds
PIP2 and another one consists of mRFP-FKBP12 fusion protein and an enzyme (for example
phosphoinositide 5-phosphatase)[7, 10, 11]. Fluorescent protein domains, mRFP and FKBP12
domain, enable visualization of the changes in PIP2 concentration, where as FRB and FKBP12
protein domains allow for the two protein constructs to heterodimerize in the presence of
rapamycin. This leads to subsequent hydrolysis of PIP2 by the enzyme present in the second
protein construct.
Before heterodimerization, there should be two distinct colors seen under the
fluorescent microscope due to CFP and FKBP12 domain (blue and red color respectively). Upon
heterodimerization of the two protein constructs we expect an appearance of one uniform
color instead of two. This way we should be able to determine a relative position of the two
constructs in Xenopus oocytes.

Figure 2.1. Protein constructs used in rapamycin induced targeting of 5-phosphatase to specific
sites at the cell membrane. This figure depicts the process in which FKBP12 protein domain
heterodimerizes with a FRB protein domain, in a process that is a principle of drug-induced
targeting. [11]
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All of those constructs were tested only in mammalian cells. We are planning to create
similar constructs that will later on be used to test the effects of PIP 2 concentration on the
activity of different potassium ion channels using Xenopus oocyte as a model organism. Unlike
mammalian cells, Xenopus oocytes have their own source of nutrients, which causes no need
for an external media to support cell growth. Other advantages of using Xenopus oocytes as a
model organism rather than mammalian cells, include but are not limited to their large size,
extremely high capacity for protein synthesis (200-400 ng protein per day per oocyte), and
relative abundance [12]. There can be more electrochemical measurements done in one day
using Xenopus oocyte than with a mammalian cell. Stage VI Xenopus oocyte is approximately
105 times larger than a nucleus of a mammalian, this will enable us to visualize the changes in
the oocyte much easier than when using a mammalian cell [12]. More importantly, the
available technology enables injection of the constructs without altering the integrity of the
cell.
In this project we were able to successfully create a construct that will be used in
expression of a mRFP-FKBP12 fusion protein in Xenopus oocytes. This will be used as a negative
control in the system shown in figure 2.1.

METHODS AND MATERIALS

PCR:
PCR was used to introduce Hind III cut site into a mRFP-FKBP12 domain containing
plasmid (pERFP). A 50µL PCR reaction was prepared using approximately 200ng of pERFP
plasmid, 0.5µM final concentration of forward and reverse PFU create-Hindi III primers, 1µL of
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dNTP mix, 1X final concentration of 10X reaction buffer, 1.5µL of Quick Solution Reagent, and
1µL of PFU DNA polymerase. The PCR reaction was performed in MJ Mini Personal Thermal
Cycler from Bio-Rad. Thermal cycles consisted of initial denaturation cycle at 95˚C for 2
minutes, followed by 18 cycles with 95˚C denaturation temperature, annealing at gradient of
55˚C, 56.2˚C, 58.4˚C, 61.3˚C, 64.9˚C, and extension at 68˚C for 5 minutes.

Transformation:
Transformation was used to screen for the cells containing the mutation (Hind III cut
site), ligation products, as well as for the unmethylated copies of pERFP plasmid (template
DNA). Home-made competent cells were thawed on ice for approximately 30minutes. 45 µL
aliquot of those cells was transferred to BD Falcon polypropylene round-bottom tube (Catalog
#352059) and mixed with 2.0µL (approximately 5µg) of vector DNA containing the mutation
(pERFP + Hind III plasmid). The DNA and the cells were incubated on ice for an additional
30minutes. After the incubation the cells were subjected to heat shock for 45seconds at 42˚C in
a water bath, and diluted with 0.5mL of NZY medium. The mixture was incubated for
approximately 1hour at 37˚C with vigorous shaking at 225rpm. The resulting product was plated
on kinamycin (ampicilin in the case of ligation products) agar plates at 37˚C for approximately
16hours. A control reaction was used to eliminate false positive results.
During the screening process 4 colonies were chosen from the transformation plate
containing a product of 58.4 ˚C PCR reaction. They were transferred into separate LB falcon
tubes containing 8mL of LB medium and 16 µL of 500X kinamycin (no antibiotic in the case of
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ligation products), using pipette tips. The cultures were incubated for approximately 12 hours
with shaking at 225rpm at 37˚C.
The plasmid was purified from the resulting medium using QIAprep Spin Miniprep Kit
(Cat. No. 27104) from Qiagen (procedure closely followed the protocol that accompanies the
kit). Concentration of the purified plasmid was measured using a nano-drop instrument.

Restriction Enzyme Digestion:
The product of thermal cycling was treated with 1 µL of Dpn I restriction enzyme in
order to digest the methylated, parental template.
Once enough pERFP + Hind III plasmid was prepared, another two 50µL double digestion
reactions were set up. One consisted of 5µg of pERFP + Hind III plasmid, 1µL of Hind III
restriction enzyme, 1µL of Nhe I restriction enzyme, 5µL of 10XBSA, and 5µL of 10XBuffer 2.
Second reaction consisted of 5µg of pMAX(+) plasmid, 1µL of Hind III restriction enzyme, 1µL of
Xba I restriction enzyme, 5µL of 10X BSA, and 5µL of 10X Buffer 2.
All of the enzymes and buffer 2 were obtained from New England Bio-labs. The
reactions were incubated overnight (approximately 12 hours) in 37˚C water bath.

Dephosphorylation of pMAX(+):
1μL of Calf Intestinal alkaline phosphatase (CIP) was used to dephosphorylate the ends
of DNA fragments of the vector (pMax(+) plasmid) after double digestion. The DNA sample and
an enzyme were incubated overnight (approximately 12 hours) in a 37˚C water bath. Total
reaction volume was 51μL and it contained approximately 5μg of DNA.
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Gel Electrophoresis:
Gel electrophoresis was used to separate the DNA fragments of interest after double
digestion. First about 200ml of 0.8% agarose gel solution was prepared using electrophoresis
grade agarose and a running buffer (40mM Tris-acetate, 1mM EDTA). The resulting solution was
heated in a microwave oven until agarose completely dissolved. The solution was poured into
the gel-casting unit with a comb in place after it cooled to about 60˚C (on standing). The
samples were prepared by adding 6X-loading buffer to bring it to a final concentration of 1X
loading buffer (0.04% Bromophenol Blue, 8.3mM EDTA, 6.7% sucrose). When the gel solidified
completely the comb was removed and the running buffer was poured over the gel. Finally 20µl
of the samples were loaded into each well and the current was applied using Power Pac Basic
from Bio-Rad.
After band separation the gel was removed from the casting and soaked in
2.5µg/mL Ethidium bromide solution for approximately 30 minutes. The appropriate bands
were cut out using a razor under the Ultra Violet light. QuickClean DNA Gel Extraction Kit form
Gen Script Corporation was used in order to purify the DNA fragments from the agarose gel,
followed by second purification step using QuickClean 5M PCR Purification Kit from GenScript
(Cat. No. L00198). In all purification procedures protocols included in the kits were closely
followed.
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Ligation:
Rapid DNA Dephos and Ligation Kit from Roche (Cat. No. 04 898 117 001) was used to
ligate vector and insert DNA.
Ligation reaction was prepared using approximately 122.5ng of vector DNA, and 73.5ng
of insert DNA(mRFP-FKBP12 domain of pERFP plasmid) in a total volume of 7μL, following an
addition of 2μL of 5X Buffer included in the kit. The reaction was mixed by centrifugation. Next,
10μL of 2X Buffer (included in the kit) and 1μL of T4 DNA Ligase were added and the sample
was mixed well once again.
The sample was incubated at room temperature for approximately one and a half hour.
There was a control reaction prepared in which insert DNA was substituted with dH 2O. The
control reaction was treated in the same fashion as the reaction containing the insert DNA.

Verification of the identity of the product:
Purified plasmid DNA was digested using Sac I and Not I restriction enzymes. 2µg of DNA
was mixed with 5μL of 10XBuffer 1 (10X Buffer 3 in the case of Not I restriction enzyme) from
New England Bio-labs, 5μL of 10XBSA, and 1μL of Sac I or Not I restriction enzyme from New
England Bio-labs. The reaction mixtures were incubated overnight in a 37˚C water bath.
The identity of products of the above digestion reactions were confirmed using gel
electrophoresis. The procedure was the same as described above.
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RESULTS:

The results presented in this paper show that we were able to successfully create a
plasmid that will be transcribed into cRNA using T7 RNA polymerase, and then injected into
Xenopus oocyte, where it will be translated into mRFP-FKBP12 fusion protein.

Introduction of Hind III digestion site:
Since the pMAX(+) plasmid already contains a Hind III cut site and the pERFP plasmid
does not, it was necessary to use site directed mutagenesis in order to introduce one into the
pERFP plasmid. It was important in the portion of the project in which we attempted to ligate
the mRFP-FKBP12 domain of pERFP plasmid with pMAX(+) plasmid.
Site directed mutagenesis consisted of 18 PCR cycles, DpnI restriction enzyme digestion
and transformation. 58.4˚C annealing temperature proved to be the best for the introduction of
the Hind III digestion site into pERFP plasmid. We were able to successfully transform the
resulting product onto the Kinomycin agar plates shown in Figure 2.2a. The lack of colonies on
the control plate (Figure 2.2b) indicates that there were no false positive results on the
transformation plate (Figure 2.2a). Later digestion of the DNA purified from the transformed
colonies has also proven that the Hind III digestion site was successfully introduced into the
pERFP plasmid. This can be seen on the agarose gel shown in figure 2.3.
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A

B

Figure 2.2. Kinamycin agar plates containing transformed 58.4˚C PCR reaction and control reaction. This figure
shows the results of plating transformed pERFP plasmid containing Hind III digestion site along with the control plate.
This sample was prepared using 58.4˚C annealing temperature. A) Transformation Plate- multiple colonies are
present. Only 4 of those colonies were used further in this project B) Control Plate- no colonies are present.

Table 2.1. Concentration and purity of pERFP plasmid containing Hind III digestion site.

Colony #

A260 10nm path

A280 10nm path

A260/A280

A260/A230

Concentration [ng/µL]

1
2
3

7.620
367.7
417.1

4.014
3.860
4.386

1.9
1.9
1.9

2.37
2.38
2.31

381.0
367.7
417.1

Purity and concentration parameters measured for the PCR product, using nano-drop
instrument, are recorded in table 2.1.
We did not see any colonies on the control plate. This result was expected and proves
that PCR reaction was performed correctly. Purity and concentration parameters measured for
the PCR product, using nano-drop instrument, are recorded in table 2.1. Concentrations of
purified plasmid were quite high and the samples appeared to be pure since both absorbance
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rations were higher than 1.8. This data shows that those samples were well suited for further
use in the project.

Excision of mRFP-FKBP12 domain and preparation of pMAX(+) plasmid:
In order to isolate the mRFP-FKBP12 domain we used double digestion with Hind III and
Nhe I digestion enzyme. We verified the identity of the digestion product using gel
electrophoresis (Figure 2.3). The contents of each line in the agarose gel are listed in table 2.2.
Both enzymes had compatible buffer requirements what enabled us to perform double
digestion in one step instead of performing two single digestions.
Table 2.2. Lane content in the agarose gel prepared for
double digesion product of pERFP plasmid.

Line

Contents

1

Traces of 1kb DNA ladder

2

1kb DNA ladder

3

Digested pERFP+Hind III plasmid

4

Digested pERFP+Hind III plasmid

5

Digested pERFP+Hind III plasmid

6

Digested pERFP+Hind III plasmid

7

Digested pERFP+Hind III plasmid

8

Digested pERFP+Hind III plasmid

Figure 2.3. Gel electrophoresis for double digested mRFP –FKBP12 domain containing plasmid. This figure
shows the results of double digestion of pERFP+Hind III plasmid. The plasmid underwent digestion by Hind III and
Nhe I restriction enzymes producing two bands one around 5kb and another around 1.3kb positions on the
agarose gel.
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The bands’ separation occurred as expected. Nhe I cuts mRFP-FKBP12 domain
containing plasmid at around 600bp and Hind III cuts at around 1670bp position along 6.2kb
long plasmid. Therefore, double digestion of the pERFP+Hind III plasmid should produce two
fragments, one about 5.0kb long and a second one about 1.3kb long. Those results can be seen
in figure 2.3 where the two bands can be clearly seen.
In order to prepare pMAX(+) plasmid for ligation we digested it with Xba I and Hindi III
restriction enzymes. Just like Nhe I, Xba I has buffer requirements compatible with Hind III
restriction enzyme enabling us to perform one double digestion instead of two single restriction
enzyme digestions. Also, Nhe I and Xba I produce compatible ends, which will play an important
role in ligation. pMax(+) plasmid contains promoter region that is necessary for a transcription
of DNA into cRNA compatible with Xenopus oocyte.

Table 2.3. Lane content in the agarose gel prepared for
pMAX(+) double digesion product.

Line

Contents

1

1kb DNA ladder from NEB

2

Blank

3

Digested pMAX(+)

4

Digested pMAX(+)

5

Blank

6

Digested pMAX(+)

7

Digested pMAX(+)

8

Blank

Figure 2.4. Gel electrophoresis for double digested pMAX(+) plasmid. This figure shows the results of double
digestion of the pMAX(+) plasmid. The plasmid underwent digestion by Hind III and Xba I restriction enzymes
producing one band around the 5 kb marker on the gel electrophoresis. The second DNA piece produced due to
the digestion reaction most likely traveled off of the gel because of its small size.
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Xba I cuts the pMAX(+) plasmid at 887bp position and Hind III cuts at 929bp position.
Therefore, there should be two DNA fragments produced from double digestion of the pMAX(+)
plasmid, one band around 5.0kb marker and another one around 40bp marker along the
plasmid. The second band is too small to be visible on the gel (figure 2.4).
Concentration and purity parameters of the purified vector and insert samples are
shown in table 2.4. These values indicate that concentration of the vector DNA was much
higher than the concentration of the insert DNA. This was expected since the insert DNA was
much shorter than the vector DNA. Sample containing mRFP-FKBP12 domain was purified only
once, since second purification could cause a significant DNA loss. Two samples of purified
vector DNA were combined in the second purification step in order to increase DNA
concentration. Second purification also increased A260/A280 ratio, and therefore further purified
the samples.

Table 2.4. Purity and concentration of samples containing mRFP-FKBP12 domain and digested pMAX(+)
plasmid.

Sample

mRFP-FKBP only; 1st
purification
pMAX(+); 1st
purification
pMAX(+); 2nd
purification

A260 10nm
path

A280 10nm
path

A260/A280

A260/A230

Concentration
[ng/µL]

0.605

0.270

2.24

0.06

30.2

3.065; 2.437

1.703; 1.306

1.80; 1.87

0.65; 0.33

153.3; 121.8

4.058

2.176

1.87

2.06

202.9
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The identity of the purified vector and insert samples was once again confirmed using
agarose gel electrophoresis. The results presented in figure 2.5 prove that the prepared
samples contained digested pMAX(+) plasmid and pERFP+Hind III plasmid. It also proves that
the samples were free from contamination with other DNA fragments since only one band in
each sample lane was visible.
Table 2.5. Lane contents of the agarose gel prepared for
pure, double digested pMAX(+) plasmid and pure
mRFP-FKBP12 domain of pERFP plasmid.

Line #

Contents

1

1kb DNA ladder from NEB

2

Blank

3

Pure, digested pMAX(+) plasmid

4

Pure, digested pMAX(+) plasmid

5

Pure, digested pMAX(+) plasmid

6

Pure, digested pMAX(+) plasmid

7

Pure mRFP –FKBP12 domain

8

Pure mRFP –FKBP12 domain

Figure 2.5. Gel electrophoresis for purified pMAX(+) plasmid and mRFP –FKBP12 domain containing plasmids.
This gel was prepared to confirm the identity of the sample extracted and purified from gel electrophoresis. The
identity of the samples used in each lane is shown in table 2.5.

Incorporation of mRFP-FKBP12 domain into pMAX(+) plasmid:
In order to create an mRFP-FKBP12 - pMAX(+) plasmid we performed ligation of mRFPFKBP12 domain with pMAX(+) plasmid using T4 DNA Ligase. We selected for the ligation
product using transformation (Figure 2.6). Ampicillin agar plates were used since pMAX(+)
plasmid carries ampicillin resistance genes. After initial 12h incubation at 37˚C only 3 colonies
were visible on the ligation plate, two of which are circled in red (Figure 2.6A). The plates were
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accidentally left in 37˚C for additional 12h what caused an appearance of other colonies (false
positives).
The control plate contained no colonies (Figure 2.6B). This was an expected result since
the control ligation reaction contained no vector DNA.

A

B

Figure 2.6. Transformed and plated product of ligation of pMAX(+) vector with mRFP –FKBP12
domain. This figure shows the colonies that grew on a plate after the transformation of the ligation
product of vector and inset DNA. The colonies circled in red are the colonies that were visible after
the initial 12h incubation at 37˚C. The smaller colonies surrounding the area marked in red formed
after the plate was accidentally left for additional 12h at 37˚C, and were not used in this project.

Confirmation of the identity of the construct:
In order to determine the identity of our construct we used Sac I and Not I digestion of
the mRFP-FKBP12 - pMAX(+) plasmid, one reaction at a time.
The results were as expected. Both Sac I and Not I digestion products yielded two bands
each on the agarose gel. Both produced one around 5kb. Sac I, also, produced a second band
around 1.3kb, and Not I produced a second band around 1kb. These results agree with the
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digestion patterns of the two restriction enzymes. Sac I cuts the 6.4kb long mRFP-FKBP12 pMAX(+) plasmid at 590bp and 1900bp positions producing two DNA fragments, one
approximately 1.3kb in length and another one approximately 5.1kb in length. Not I restriction
enzyme cuts the construct at around 790bp and 1510bp site along the plasmid also producing
two DNA fragments. One fragment is approximately 0.7kb long, and the second one is
approximately 5.7kb long.
This exact pattern can be seen in figure 2.7 indicating that the ligation part of the
experiment was successful. We are still awaiting the results of automated sequencing which will
double check our results.

Table 2.5. Lane contents of the agarose gel prepared for the
product of digestion of mRFP-FKBP12-pMAX(+)
construct with Not I and Sac I restriction Enzymes.

Line

Contents

1

1kb DNA ladder from NEB

2

Blank

3

Not I digestion product

4

Not I digestion product

5

Blank

6

Sac I digestion product

7

Sac I digestion product

8

Blank

Figure 2.7. Gel electrophoresis for digested mRFP –FKBP12 –pMAX(+) construct. This figure shows the
agarose gel electrophoresis results for the mRFP –FKBP12 -pMAX(+) construct digested with Not I (lanes 3 and
4) and Sac I (lanes 7 and 8). This gel was used to confirm the identity of the ligation products. Identities of the
samples loaded in each lane are listed in table 2.5.
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DISCUSSION:

The data presented above indicates that we have succeeded in creating a DNA plasmid
required for expression of mRFP-FKBP12 fusion protein in Xenopus oocytes. At each stage we
were able to obtain DNA of good quality. After each purification step the DNA concentration of
the samples was relatively high. The quality of the samples was measured using A260/A280 ratios,
which are indicative of protein contamination. In each case this ratio was higher or at least
equal to 1.8. This means that these samples had good enough quality to be used in the further
stages of the experiment and the protein concentration in the samples was small enough so
that it would not inhibit any of the enzymatic reactions that had to be carried out after
purification.
The identity of the DNA samples was successfully confirmed using gel electrophoresis
before and after the ligation stage of this project. The pERFP plasmid was successfully digested
at two sites, producing DNA fragment of interest (fragment containing mRFP- FKBP12 domain).
This fragment is about 1.3kb in size and has ends compatible to the DNA fragment produced by
double digestion of the pMAX(+) plasmid.
Ligation results were confirmed in the same fashion. First, the use of control plate
ensured that there were no false positive results, since there were no colonies visible on that
plate. Then the double digestion resulted in the expected bands on the agarose gel. According
to the genetic map of the mRFP –FKBP12-pMAX(+) plasmid it has two Not I digestion sites, at
590bp and 1900bp positions along the nucleotide chain. Since this plasmid is expected to be
about 6.4 kb long, Not I digestion should yield two DNA fragments, one about 1.3kb and the
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other about 5.1kb long. Similarly, there are two Sac I digestion sites at the 790bp and 1510bp
positions of the nucleotide chain. Digestion with this restriction enzyme was expected to
produce fragments about 1kb and 5kb long. Since the bands on the agarose gel containing the
digested samples revealed the pattern very close to the one just described, we can be quite
sure that the product of the ligation reaction is indeed the mRFP –FKBP12-pMAX(+) plasmid. To
double check these results, the samples were also sent for automated sequencing.
Once the data is fully confirmed, so that there is no doubt as to the sequence of
designed plasmid, we will proceed to transcription of this DNA into cRNA using T7 RNA
polymerase. This nucleotide chain will then be used in the studies of the activity of potassium
ion channels using Xenopus oocytes as a model organism. The construct prepared in this
project will be used as a negative control since it lacks the 5-phosphatase domain. It will be able
to heterodimerize with FRB-CFP construct but will not be able to dephosphorylate PIP 2 leaving
its concentration unchanged.
Injection of cRNA into Xenopus oocytes are expected to result in 100% of the injected
genetic material being translated into protein products which will enable us to easily
manipulate the concentration of the protein constructs in the oocyte [12]. The efficiency of the
translation will be visible due to the mRFP portion of the construct.
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CONCLUSION:

The only conclusion that can be made at this stage is that the construct was successfully
created. This is confirmed by multiple pieces of data, most importantly gel electrophoresis of
two cut digestions by Not I and Sac I restriction enzymes presented in figure2.7. Those results
will also be confirmed using automated sequencing analysis performed by a second party.
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